<DOC>
	<DOC>NCT01476488</DOC>
	<brief_summary>This study was designed to compare the pharmacokinetics of Prograf and Advagraf in stable pediatric kidney transplant recipients. Enrolled patients on prograf will have pharmacokinetic study of tacrolimus for 24 hours and after that, the same dose of advagraf will be prescribed. The patients will have another pharmacokinetic study of tacrolimus after conversion to advagraf.</brief_summary>
	<brief_title>Conversion of Prograf to Advagraf in Pediatric Renal Transplant Recipients</brief_title>
	<detailed_description />
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>ABOcompatible kidneyonly transplantation more than 1 year after kidney transplantation 5 to 15 years old patients maintained on Prograf tacrolimus level of determined previously: 4 to 20 ng/ml eGFR by Schwartz equation &gt; 50mL/min patients with acute rejection within 90 days patients with acute rejection requiring antibody therapy within 6 months patients with more than 2 times of acute rejection within 1 year AST/ALT 2 times more than upper normal limit ABOincompatible or crossmatchpositive transplantation multiorgan transplantation</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>